Characteristics of bloodstream infections in burn patients: An 11-year retrospective study

Burns : Journal of the International Society for Burn Injuries
Bhavik M PatelJason A Roberts

Abstract

The principal aim of this study was to describe infection related characteristics of blood stream infections (BSI) in patients with burns. We sought to determine the organisms that caused BSI and factors that could predict the outcome of BSI. Data was collected on admitted patients with burns from January 1998 to December 2008. Selected information from databases was analysed using SPSS version 17 (SPSS Inc., Chicago). Descriptive, univariate and multivariate analysis was undertaken to determine factors predictive of clinical outcome. The factors analysed by univariate analysis were selected on clinical plausibility. Multivariate analysis used a crosstabs procedure initially to estimate maximum likelihood. Factors that were associated with a p value <0.15 were entered into a binary logistic regression to detect which factors were independent predictors of mortality in BSI and outcome according to specific organisms. Ninety-nine out of 2364 (4%) patients developed 212-documented BSI. The median time from burn to BSI was 7 (interquartile range 3-16) days. Gram-positive organisms, in particular Methicillin resistant Staphylococcus aureus and Coagulase negative Staphylococci, were the most common bacteria associated with BSI in the...Continue Reading

References

Jun 1, 1988·American Journal of Infection Control·J S GarnerJ M Hughes
Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Apr 12, 2001·The British Journal of Surgery·M J MullerM R Rule
Feb 9, 2002·Burns : Journal of the International Society for Burn Injuries·Pia AppelgrenUlrika Ransjö
Oct 12, 2004·Burns : Journal of the International Society for Burn Injuries·Neelam TanejaMeera Sharma
Nov 9, 2006·Journal of Burn Care & Research : Official Publication of the American Burn Association·David A EdelmanRobert F Wilson
Oct 11, 2007·Journal of Burn Care & Research : Official Publication of the American Burn Association·David G GreenhalghUNKNOWN American Burn Association Consensus Conference on Burn Sepsis and Infection Group
Nov 13, 2007·Burns : Journal of the International Society for Burn Injuries·Harvey ChimColin Song
Jan 27, 2009·Burns : Journal of the International Society for Burn Injuries·Merlin GuggenheimPietro Giovanoli
Sep 29, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Omar M Al-RawajfahJeanne Beauchamp Hewitt
Jan 12, 2010·Journal of Burn Care & Research : Official Publication of the American Burn Association·Wendy L WahlMark R Hemmila
Jul 10, 2010·Journal of Burn Care & Research : Official Publication of the American Burn Association·Jeffrey W ShuppShmuel Shoham
Oct 23, 2010·Burns : Journal of the International Society for Burn Injuries·Patrick MaharJason Wasiak

❮ Previous
Next ❯

Citations

Nov 21, 2013·Burns : Journal of the International Society for Burn Injuries·Steven E Wolf, Brett D Arnoldo
Dec 4, 2013·Burns : Journal of the International Society for Burn Injuries·Oral ÖncülLevent Görenek
Nov 20, 2012·Burns : Journal of the International Society for Burn Injuries·Ayelet Raz-PasteurDana Egozi
Feb 24, 2015·Critical Care Medicine·Jennifer D ParatzRobert J Boots
Oct 10, 2015·Infection·Alexandra CenicerosDavid Freire
Jun 1, 2016·Burns : Journal of the International Society for Burn Injuries·Jian FransénHåkan Hanberger
Dec 28, 2016·Plastic and Reconstructive Surgery·Kevin J ZuoEdward E Tredget
Jun 27, 2015·Journal of Intensive Care Medicine·Jonathan B LundyBruce C Friedman
Sep 14, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Geeta SoodPeter Pronovost
May 5, 2020·Surgical Infections·Josephine A D'Abbondanza, Shahriar Shahrokhi
May 30, 2020·Surgical Infections·Kathryn LagoDana Blyth
Oct 25, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L E PiriiE Bathoorn
Feb 11, 2021·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Eng-Kean Yeong, Wang-Huei Sheng
Jun 5, 2021·Toxicon : Official Journal of the International Society on Toxinology·Parvaneh BevalianKamran Pooshang Bagheri
Jul 2, 2021·Antimicrobial Resistance and Infection Control·Yangmin HuHaibin Dai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Burns : Journal of the International Society for Burn Injuries
L S Nakhla, R Sanders
Burns : Journal of the International Society for Burn Injuries
Ting Hway WongColin Song
Burns : Journal of the International Society for Burn Injuries
Zulal OzkurtMufide N Akcay
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Omar M Al-RawajfahJeanne Beauchamp Hewitt
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Anthony D HarrisMary-Claire Roghmann
© 2022 Meta ULC. All rights reserved